BRISTOL INVESTMENT FUND LTD's Net Worth

$47.5 Million

Estimate Recalculated Nov 1, 2024 02:23PM EST

Who is BRISTOL INVESTMENT FUND LTD

BRISTOL INVESTMENT FUND LTD has an estimated net worth of $47.5 Million. This is based on reported shares across multiple companies, which include INNOVATIVE CARD TECHNOLOGIES INC, Genesis Biopharma, Inc, Research Solutions, Inc., and OXIS INTERNATIONAL INC.

SEC CIK

BRISTOL INVESTMENT FUND LTD's CIK is 0001174866

Past Insider Trading and Trends

2016 was BRISTOL INVESTMENT FUND LTD's most active year for acquiring shares with 4 total transactions. BRISTOL INVESTMENT FUND LTD's most active month to acquire stocks was the month of February. 2020 was BRISTOL INVESTMENT FUND LTD's most active year for disposing of shares, totalling 31 transactions. BRISTOL INVESTMENT FUND LTD's most active month to dispose stocks was the month of July. 2013 saw BRISTOL INVESTMENT FUND LTD paying a total of $3,889,770.00 for 390,012,087 shares, this is the most they've acquired in one year. In 2013 BRISTOL INVESTMENT FUND LTD cashed out on 3 shares for a total of $2,000,000.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INNOVATIVE CARD TECHNOLOGIES INC

Investor
Updated May 09, 2005
Form 4
May 09, 2005
1.03M
Options
May 05
Form 3
May 05, 2005
500.00K
Showing 2 results

Research Solutions, Inc.

Investor
Updated Sep 19, 2023
Form 4
-44.54%
-1.15M
$2.45
-$2.82M
Sep 19, 2023
1.44M
Sale
Sep 18
Form 3
Aug 07, 2023
2.59M
Form 4
-10.47%
-301.82K
$2.29
-$691.02K
Dec 31, 2020
2.58M
Sale
Dec 30 - Dec 31
Form 4
-11.91%
-390.00K
$2.27
-$884.83K
Dec 23, 2020
2.88M
Sale
Dec 22
Form 4
-0.99%
-32.75K
$2.30
-$75.16K
Dec 04, 2020
3.27M
Sale
Dec 03
Form 4
-1.57%
-52.81K
$2.28
-$120.42K
Nov 02, 2020
3.31M
Sale
Oct 30
Form 4
-2.08%
-71.37K
$2.30
-$163.87K
Oct 22, 2020
3.36M
Sale
Oct 21 - Oct 22
Form 4
-1.78%
-62.10K
$2.33
-$144.86K
Oct 08, 2020
3.43M
Sale
Oct 07 - Oct 08
Form 4
-2.78%
-100.00K
$2.40
-$240.11K
Sep 21, 2020
3.49M
Sale
Sep 18
Form 4
-3.79%
-141.44K
$2.61
-$369.18K
Sep 11, 2020
3.59M
Sale
Sep 10 - Sep 11
Form 4
-1.90%
-72.18K
$2.44
-$176.28K
Sep 04, 2020
3.73M
Sale
Sep 03 - Sep 04
Form 4
-3.21%
-126.10K
$2.50
-$314.71K
Aug 27, 2020
3.81M
Sale
Aug 26 - Aug 27
Form 4
-2.94%
-119.05K
$2.42
-$288.10K
Aug 20, 2020
3.93M
Sale
Aug 19 - Aug 20
Form 4
-4.04%
-170.64K
$2.55
-$435.84K
Aug 11, 2020
4.05M
Sale
Aug 10 - Aug 11
Form 4
-2.91%
-126.56K
$2.46
-$311.47K
Aug 06, 2020
4.22M
Sale
Aug 05 - Aug 06
Form 4
-4.40%
-200.00K
$2.35
-$469.74K
Aug 03, 2020
4.35M
Sale
Jul 31 - Aug 03
Form 4
-1.60%
-73.75K
$2.36
-$173.71K
Jul 20, 2020
4.55M
Sale
Jul 17
Form 4
-1.02%
-47.66K
$2.32
-$110.49K
Jul 07, 2020
4.62M
Sale
Jul 06 - Jul 07
Form 4
-0.63%
-29.47K
$2.48
-$72.94K
Jun 30, 2020
4.67M
Sale
Jun 29 - Jun 30
Form 4
-2.61%
-125.96K
$2.64
-$332.32K
Jun 26, 2020
4.70M
Sale
Jun 25 - Jun 26
Form 4
0.77%
36.86K
$8.20
$302.19K
Mar 22, 2016
4.82M
Purchase
Mar 17 - Mar 18
Form 4
0.04%
2.00K
$1,270.00
$2.54M
Mar 03, 2016
4.79M
Purchase
Feb 29
Form 4
3.52%
162.50K
$2.00
$325.00K
Nov 15, 2013
4.78M
Purchase
Nov 13
Form 3
Nov 17, 2008
2.65M
Showing 24 results

Genesis Biopharma, Inc

Investor
Updated Nov 07, 2014
Form 4
-2.52%
-100.00K
$6.90
-$690.00K
Nov 07, 2014
3.87M
Sale
Nov 06
Form 4
3,889.31%
389.85M
$1,000,000.01
$1.56M
Jun 04, 2013
399.87M
Options
May 22
Form 3
Jun 11, 2012
10.01M
Showing 3 results

OXIS INTERNATIONAL INC

Investor
Updated Apr 05, 2016
Form 4
-17.60%
-425.00K
$0.45
-$303.75K
Apr 05, 2016
1.99M
Sale
Apr 04 - Apr 05
Form 3
Mar 02, 2016
2.56M
Form 3
Jan 25, 2016
2.44M
Showing 3 results